Published in Front Biosci on May 01, 2006
Alternative splicing of the first intron of the steroid receptor RNA activator (SRA) participates in the generation of coding and noncoding RNA isoforms in breast cancer cell lines. DNA Cell Biol (2006) 1.33
Psoriasin interacts with Jab1 and influences breast cancer progression. Cancer Res (2003) 1.20
Identification of a novel breast- and salivary gland-specific, mucin-like gene strongly expressed in normal and tumor human mammary epithelium. Cancer Res (2002) 1.10
Increasing the relative expression of endogenous non-coding Steroid Receptor RNA Activator (SRA) in human breast cancer cells using modified oligonucleotides. Nucleic Acids Res (2009) 1.07
Identification of new human coding steroid receptor RNA activator isoforms. Biochem Biophys Res Commun (2003) 1.04
Steroid Receptor RNA Activator bi-faceted genetic system: Heads or Tails? Biochimie (2011) 1.00
A novel hypoxia-inducible spliced variant of mitochondrial death gene Bnip3 promotes survival of ventricular myocytes. Circ Res (2011) 0.98
Claudin 1 in breast tumorigenesis: revelation of a possible novel "claudin high" subset of breast cancers. J Biomed Biotechnol (2010) 0.98
Estrogen receptor alpha negative breast cancer patients: estrogen receptor beta as a therapeutic target. J Steroid Biochem Mol Biol (2007) 0.98
Claudins 1, 3, and 4 protein expression in ER negative breast cancer correlates with markers of the basal phenotype. Virchows Arch (2009) 0.96
The steroid receptor RNA activator protein is expressed in breast tumor tissues. Int J Cancer (2006) 0.96
The role of estrogen receptor-β in breast cancer. Semin Reprod Med (2012) 0.95
Expression analysis of the mouse S100A7/psoriasin gene in skin inflammation and mammary tumorigenesis. BMC Cancer (2005) 0.92
Differential expression of claudin 1, 3, and 4 during normal mammary gland development in the mouse. DNA Cell Biol (2006) 0.90
The protein encoded by the functional steroid receptor RNA activator is a new modulator of ER alpha transcriptional activity. FEBS Lett (2010) 0.89
Relationship between mammaglobin expression and estrogen receptor status in breast tumors. Endocrine (2003) 0.88
Steroid Receptor RNA Activator Protein (SRAP): a potential new prognostic marker for estrogen receptor-positive/node-negative/younger breast cancer patients. Breast Cancer Res (2009) 0.88
The steroid receptor RNA activator protein is recruited to promoter regions and acts as a transcriptional repressor. FEBS Lett (2010) 0.86
RNA-dependent dynamic histone acetylation regulates MCL1 alternative splicing. Nucleic Acids Res (2013) 0.86
Claudin 1 expression in basal-like breast cancer is related to patient age. BMC Cancer (2013) 0.84
Real-time PCR complements immunohistochemistry in the determination of HER-2/neu status in breast cancer. BMC Clin Pathol (2006) 0.83
Gene expression profiling of early involuting mammary gland reveals novel genes potentially relevant to human breast cancer. Front Biosci (2007) 0.81
Steroid receptor RNA activator protein (SRAP) expression as a prognostic factor in ER+ human breast tumors. J Cancer Res Clin Oncol (2013) 0.80
Deficiency of prolactin-inducible protein leads to impaired Th1 immune response and susceptibility to Leishmania major in mice. Eur J Immunol (2015) 0.79
Developmental changes in insulin-like growth factor I receptor gene expression in the mouse mammary gland. Endocr Res (2004) 0.79
Computational modelling of protein interactions: energy minimization for the refinement and scoring of association decoys. Acta Biotheor (2009) 0.78
Expression of the mouse homologue for the human GCDFP-15/PIP gene during pre- and early post-natal development. Mol Cell Endocrinol (2003) 0.78
Identification of an octamer-binding site controlling the activity of the small breast epithelial mucin gene promoter. Front Biosci (2006) 0.77
Targeted production of proprotein convertase PC1 enhances mammary development and tumorigenesis in transgenic mice. Can J Physiol Pharmacol (2009) 0.76
Expression of two breast-specific molecules in the lung. J Mol Diagn (2006) 0.75
Idiopathic Hypogonadotropic Hypogonadism Caused by Inactivating Mutations in SRA1. J Clin Res Pediatr Endocrinol (2016) 0.75
Inducible expression of dominant negative insulin-like growth factor I receptor in MCF-7 breast cancer cells. Endocrine (2003) 0.75